海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
219件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients Who Are Apolipoprotein E e4 Carriers
- Alzheimer Disease MedDRA version: 14.1 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Chile, Croatia, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Portugal, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2008-02-22
Not Recruiting
- Influence of genetic risk APOE on cognitive processing of elderly with Alzheimer's disease and healthy elderly
- Alzheimer's disease C10.228.140.380.100;F00-F99;C10.228.140.380.100
- Brazil
- 2018-07-10
Authorised
- An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)
- mild to moderate Alzheimer's Disease MedDRA version: 15.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Portugal, Spain, Turkey, United Kingdom, United States
- 2012-10-02
Recruiting
- 5-fluorouracil 5% compared to vitamin b3 in the treatment of precancerous skin changes
- Actinic keratosis L57.0;L00-L99
- Brazil
- 2016-11-24
Not Recruiting
- A Long Term Safety and Efficacy Trial of MK-8931 (SCH 900931) in Subjects with Prodromal AD (APECS).
- Prodromal Alzheimer's Disease MedDRA version: 20.0 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes) System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Finland, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Poland, Spain, Switzerland, United Kingdom, United States
- 2015-08-27
Not recruiting
- Initial Combination With Pioglitazone Study (0431-064)
- Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus;Type 2 Diabetes Mellitus
- Brazil, Chile, Costa Rica, Czech Republic, India, Korea, Republic of, Lithuania, Malaysia, Peru, Philippines, Poland, Puerto Rico, Russian Federation, United States
- 2006-11-08
Not recruiting
- Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
- Acute Heart Failure;Acute Heart Failure;Acute Heart Failure
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Czechia, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States
- 2013-06-03
Not recruiting
- GALLANT 6 Tesaglitazar vs. Pioglitazone
- Diabetes Mellitus, Type 2
- Argentina, Brazil, Canada, Finland, Mexico, Norway, United Kingdom, United States
- 2005-09-20
Not Recruiting
- FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
- Conjunctivitis due to adenovirus
- Brazil, India, United States of America
- 2012-06-14
Authorised
- To evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD)
- Alzheimer's disease MedDRA version: 19.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Austria, Belgium, Canada, Chile, China, Finland, France, Germany, Hong Kong, Iceland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Singapore, South Africa, Spain, Taiwan, United Kingdom, United States
- 2017-03-31
